Phio Pharmaceuticals Corp. (PHIO)

NCM – Real Time Price. Currency in USD

1.08

-0.01 (-1.03%)

Market open: Aug 12, 2026, 11:14 AM EDT

1.09

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:10 PM EDT

06.08.2026

Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update

Strategic milestone advancements for lead clinical candidate PH-762 Initiation of commercial scale API, long term non-clinical toxicology, completion of Phase 1b pharmacology, and new IP announcements King of Prussia, Pennsylvania--(Newsfile Corp. - August 6, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio today reported its financial results for the quarter ended June 30, 2026, and provided a business update.

Videos

No Data

There is no data to display

Press releases

06.08.2026

Phio Pharmaceuticals Corp. (PHIO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Phio Pharmaceuticals Corp. (PHIO)

Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update

Videos

No Data

Press releases

Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update

Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update

Videos

No Data

Press releases

Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update

Search stocks

Phio Pharmaceuticals Corp. (PHIO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Phio Pharmaceuticals Corp. (PHIO)

Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update

Videos

No Data

Press releases

Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update

Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update

Videos

No Data

Press releases

Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update